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Introduction
The 1000 Genomes Project started in 2008 with the aim of producing a deep catalogue of human genomic 
variation and, for this, more than 2600 samples from 26 different populations were sequenced. The project 
completed its final phase (named phase three) in 2015, with the release of more than 85 million variants of vari-
ous types and phased haplotypes for those variants1. This data has been widely used by the scientific community 
for genotype imputation and many other applications2. The strategy adopted by the project consisted of sequenc-
ing samples using whole genome sequencing (WGS) and whole exome sequencing (WES), and the alignment of 
that sequence data to a version of the GRCh37 human reference genome, which included decoy sequences for 
optimal read mapping.
While the 1000 Genomes Project was based on GRCh37, the latest version of the human reference assembly 
(GRCh38) was released by the Genome Reference Consortium (GRC) in 2013 and is the current best representa-
tion of the human genome available [PMID: 28396521]. This updated assembly has the following fundamental 
improvements with respect to its predecessors: 
•    corrects thousands of small sequencing artifacts and misassembled regions in addition to filling or 
reducing more than 100 gaps
•    includes synthetic centromeric sequences that previously were represented in the reference by gaps of three 
million base pairs
•    improves the diversity of the reference by including new alternate sequences, to address the fact that some 
genomic regions are highly variable
By improving the reference genome, GRCh38 improves the foundation for calling variation by providing both a 
more accurate and more diverse representation of the genome, thereby enabling better read mapping and reducing 
opportunities for erroneous variation calls.
To make full use of GRCh38, there has been a need for widely used genomic reference data sets, like the 1000 
Genomes data, to be made available on the assembly, so that pipelines and analyses that rely on such additional 
reference materials can use GRCh38 and benefit from its improvements.
dbSNP have facilitated the use of the 1000 Genomes variation data on GRCh38 by “lifting-over” the calls, using 
a method relying on an alignment created between GRCh37 and GRCh38. The alignment is then used to deter-
mine equivalent locations between the two assemblies, allowing variation data to be “lifted-over”. Files from 
dbSNP are reformatted into a standard VCF by the European Variation Archive (EVA) and shared as part of our 
resources through the 1000 Genomes FTP site and also via the Ensembl genome browser [PMID: 30407521].
Lift-over approaches, however, have several limitations. 1) Necessarily, they rely on an equivalent region existing 
in the new genome, so new sequence in the improved assembly is effectively excluded. 2) Reliable transfer requires 
a good mapping between the assemblies, covering not just a given variation but the context that was used to make 
that call—it may be possible to “lift-over” a SNP where the data supporting the original call would not lift-over. 
Where the context of a call alters, the data becomes less reliable. 3) While lift-overs can give an approximation of 
the variant sites on the new assembly the results will differ from calling directly on the new assembly, the latter 
taking advantage of the increased representation of genomic sequence, assembly corrections and making calls from 
the underlying read data in context. With the above in mind, and given that the 1000 Genomes data is a heavily used 
resource, we decided to create a new call set from alignments of the original 1000 Genomes read data to GRCh38.
The first step was alignment of the 1000 Genomes sequence data to the GRCh38 as previously described3. These 
alignments were taken as the starting point in creating the variation calls described in this data note.
To generate calls from the 1000 Genomes data, we adopted a multi-caller approach, aiming to produce a 
similar quality reference call set to that produced by the 1000 Genomes Project while using a simpler methodology, 
reflecting both practical considerations and the improved understanding of the process developed by the 1000 
Genomes Project itself.
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Four supporting call sets were created, using different callers and combinations of the exome and WGS sequence 
data.
For the final call set, biallelic SNVs (single nucleotide variants) only were selected from the four supporting call 
sets. These represent the major part of the SNVs present in the human genome.
The inclusion of only biallelic SNVs generates a data set useful for many purposes, while enabling more 
streamlined data processing than is possible when handling indels and multi-allelic variants. We are thus able to 
share what we believe to be a useful data set while planning to revisit our supporting call sets and, in future, 
produce updated call sets including a broader spectrum of variation.
Methods
Input data
The methods used for sample collection, library construction, and sequencing are described in the previous 1000 
Genomes Project publications1,4,5. The read data used for this analysis followed the same criteria as the final 
phase of the 1000 Genomes Project, namely only sequence data generated by Illumina sequencing and only reads 
longer than 70 bp (WGS) and 68 bp (WES). This data was aligned to GRCh38 as previously described3. The 
complete list of the whole genome and whole exome sequencing alignment files used as the input for generat-
ing the callsets can be found on our FTP site at ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/data_collections/1000_
genomes_project/1000genomes.low_coverage.GRCh38DH.alignment.index and at ftp://ftp.1000genomes.ebi.ac.uk/ 
vol1/ftp/data_collections/1000_genomes_project/1000genomes.exome.GRCh38DH.alignment.index.
Reference genome
We used the full GRCh38 reference, including ALT contigs, decoy and EBV sequences (accession 
GCA_000001405). In addition, more than 500 HLA sequences compiled by Heng Li from the IMGT/HLA database 
provided by the Immuno Polymorphism Database (IPD) [PMID: 27899604] are included. The reference genome can 
be accessed at ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/reference/GRCh38_reference_genome/.
Ethical considerations
Information concerning ethical approval and the informed consent procedure for the 1000 Genomes project can 
be found here.
Quality control of the alignment files
We adopted a similar quality control process to that used in the final phase of the 1000 Genomes Project. 
Chk_indel_rg was applied to discard alignment files with an unbalanced ratio of short insertions and deletions (greater 
than 5). Picard CollectWgsMetrics was used with the whole genome files and those with mean non-duplicated 
aligned coverage level ≤2x were discarded. In the case of the exome files, we used Picard CollectHsMetrics using the 
exome target coordinates that can be found at ftp.1000genomes.ebi.ac.uk/vol1/ftp/data_collections/1000_genomes_
project/working/20190125_coords_exon_target/, and we kept the files having more than 70% of the target regions 
covered by 20× or greater of sequence reads.
In addition, VerifyBAMID6 was used to assess sample contamination and sample mix-ups and the following 
cutoffs were used:
• free_mix > 0.03 and chip_mix > 0.02 for whole genome files
• free_mix > 0.035 and chip_mix > 0.02 for exome files
Only files passing the quality assessment were used in subsequent variant calling.
Variant discovery
A total of 2,659 WGS and 2,498 WES BAMs were generated corresponding to 2,698 samples3 were used for 
variant identification. Figure 1 details the analysis of the alignment files with three established methods (BCFtools 
version 1.3.1-220-g9f38991, Freebayes7 version v1.0.2-58-g054b257 and GATK UnifiedGenotyper8 version 3.5-0-
g36282e4). BCFtools was used to analyse WGS and WES files in two independent runs, GATK UnifiedGenotyper 
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was used only with WGS files and Freebayes was used to analyse everything together (WGS+WES). The following 
command lines were used for each of the methods: 
              •   BCFtools with the WGS files:
bcftools mpileup -E -a DP -a SP -a AD -P ILLUMINA \
  -pm3 -F0.2 -C50 -d 700000 \
  -f $ref.fa $file.bam | bcftools call -mv -O z \
  --ploidy GRCh38 -S $samples.ped -o $out.vcf.gz
              •   GATK UnifiedGenotyper with the WGS files:
java -Xmx6g -jar GenomeAnalysisTK.jar \
  -T UnifiedGenotyper \
  -R $ref.fa \
  -I $file.bam \ 
  -o $out.vcf.gz \ 
  -dcov 250 \
  -stand_emit_conf 10 \ 
  -glm both \
  --genotyping_mode GENOTYPE_GIVEN_ALLELES \ 
  --dbsnp ALL_20141222.dbSNP142_human_GRCh38.snps.vcf.gz \
  -stand_call_conf 10
              •   BCFtools with the WES files:
bcftools mpileup -E -a DP -a SP -a AD -P ILLUMINA \
  -pm3 -F0.2 -C50 -d 1400000 \
  -f $ref.fa $file.bam | bcftools call -mv -O z \
  --ploidy GRCh38 -S $samples.ped -o $out.vcf.gz
              •   Freebayes with the WGS+WES files:
   freebayes --genotyping-max-iterations 10 \ 
  --min-alternate-count 3 \
  --max-coverage 2000000 \
  --min-mapping-quality 1 \
  --min-alternate-qsum 50 \
  --min-base-quality 3 \
  -f $ref.fa \
  -b $file.bam | bgzip -c > $out.vcf.gz
Figure 1. Schematic representation of our approach illustrating the entire process from the alignment files 
previously generated to the generation of the four supporting callsets and finally to the production of the final 
phased consensus callset. VCF, variant call format; WGS, whole-genome sequencing; WES, whole-exome sequencing; 
VQSR, variant quality score recalibration.
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Variant filtering
Our variant discovery pipeline produced four initial call sets as described above. To create the final call set, 
we discarded the variants falling in the centromeres, as these are regions of low complexity that hinder variant 
calling. Variants on the chromosome Y or in regions of the chromosome X not corresponding to the pseudoauto-
somal regions (PAR) were also discarded due to the ploidy settings used in this work. Additionally, the initial 
call sets contained spurious variants filtered using different methods and parameters depending on the call set:
GATK UnifiedGenotyper call set. We used the VariantScoreRecalibration (VQSR)8 method following the GATK 
best practices and GATK training call sets. The combination of commands and parameters we used were different 
depending on the the variant type being analysed. For SNPs we used GATK VariantRecalibrator and ApplyRecalibra-
tion as follows:
java -jar GenomeAnalysisTK.jar \
  -T VariantRecalibrator \
  -R $ref.fa \
    -input $file.vcf.gz \ -resource:hapmap,known=false,training=true,truth=true
,prior=15.0 hapmap_3.3.hg38.vcf.gz \ -resource:omni,known=false,training=tru
e,truth=true,prior=12.0 1000G_omni2.5.hg38.vcf.gz \ -resource:1000G,known=fa
lse,training=true,truth=false,prior=10.0 1000G_phase1.snps.high_confidence.
hg38.vcf.gz \ -resource:dbsnp,known=true,training=false,truth=false,prior=2.
0 dbsnp_146.hg38.vcf.gz \ 
  -an DP \
  -an QD \
  -an FS \
  -an SOR \
  -an MQ \
  -an MQRankSum \ 
  -an ReadPosRankSum \ 
  -an InbreedingCoeff \
  -mode SNP \
   -tranche 100.0 -tranche 99.9 -tranche 99.0 -tranche 98.0 -tranche 97.0 -
tranche 96.0 -tranche 95.0 -tranche 92.0 -tranche 90.0 -tranche 85.0 -
tranche 80.0 -tranche 75.0 -tranche 70.0 -tranche 65.0 -tranche 60.0 -
tranche 55.0 -tranche 50.0 \
  -recalFile recalibrate_SNP.recal \
  -tranchesFile recalibrate_SNP.tranches \ 
  -rscriptFile recalibrate_SNP_plots.R
And:
java -jar GenomeAnalysisTK.jar
  -T ApplyRecalibration \
  -R $ref.fa \
  -input $file.vcf.gz \
  -mode SNP \
  --ts_filter_level 99.9 \
  -recalFile recalibrate_SNP.recal \
   -tranchesFile recalibrate_SNP.tranches | bgzip -c > recalibrated_snps_raw_
indels.vcf.gz
And for INDELs we used:
java -jar GenomeAnalysisTK.jar \
  -T VariantRecalibrator \
  -R $ref.fa \
   -input recalibrated_snps_raw_indels.vcf.gz \ -resource:mills,known=false,tra
ining=true,truth=true,prior=12.0 Mills_and_1000G_gold_standard.indels.hg38.
vcf.gz \ -resource:dbsnp,known=true,training=false,truth=false,prior=2.0   
dbsnp_146.hg38.vcf.gz \
  -an QD \
  -an DP \
  -an FS \
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  -an SOR \
  -an ReadPosRankSum \
  -an MQRankSum \
  -an InbreedingCoeff \
  -mode INDEL \
   -tranche 100.0 -tranche 99.9 -tranche 99.0 -tranche 98.0 -tranche 97.0 -
tranche 96.0 -tranche 95.0 -tranche 92.0 -tranche 90.0 -tranche 85.0 -
tranche 80.0 -tranche 75.0 -tranche 70.0 -tranche 65.0 -tranche 60.0 -
tranche 55.0 -tranche 50.0 \
  -recalFile recalibrate_INDEL.recal \
  -tranchesFile recalibrate_INDEL.tranches \
  -rscriptFile recalibrate_INDEL_plots.R \
  --maxGaussians 4
And:
java -jar GenomeAnalysisTK.jar \
  -T ApplyRecalibration \
  -R $ref.fa \
  -input recalibrated_snps_raw_indels.vcf \
  -mode INDEL \
  --ts_filter_level 80.0 \
  -recalFile recalibrate_INDEL.recal \
   -tranchesFile recalibrate_INDEL.tranches | bgzip -c > recalibrated_variants.
vcf.gz
BCFTools call sets. We compared the distribution of the values for different variant annotations in the set of true 
positive and false positive sites and established the set of variant annotations and cutoff values used in the filtering. 
We considered true positives the sites identified in our call set for genome NA12878 that were also present in the 
gold-standard call set generated for the same sample by Genome in a Bottle (GIAB). GIAB’s calls for NA12878 
are the result of an effort to integrate data generated by 13 different sequencing technologies and analysis 
methods9. Sites that were present in our call sets and absent in GIAB were considered false positive sites. Table 1 
and Table 2 show the variant annotations and cutoff values used for the SNPs and INDELs with the low coverage 
data and Table 3 and Table 4 show the annotations and cutoff values used for the exome data with the SNPs and 
INDELs respectively. These cutoff values were applied using the following command: 
              •   SNPs from the low coverage data:
   bcftools filter -s GIABFILTER \ 
      -e'INFO/DP>24304 | MQ<34 | MQ0F>0.049737 | HOB>0.1643732 | SGB>2347.043 | 
SGB<-64440.286 | QUAL<20' \
     $file.snps.vcf.gz \
     -o $out.snps.filtered.vcf.gz -O z
              •  INDELs from the low coverage data:
   bcftools filter -s GIABFILTER \
      -e'INFO/DP>23758 | MQ<41 | MQ0F>0.009913696 | HOB>0.20265508 | SGB>2143.8876 
| SGB<-29513.557 | IDV>51 | IMF<0.387097 | QUAL<20' $file.indels.vcf.gz -o 
$out.indels.filtered.vcf.gz -O z
              •   SNPs from the exome data:
   bcftools filter -sGIABFILTER \
      -e'INFO/DP>656519 | MQ<38 | MQ0F> 0.0146629| HOB>0.1536016 | SGB>57489.21 
| SGB < -226326.93| QUAL<20' $file.snps.vcf.gz \
     -o  $out.snps.filtered.vcf.gz -O z
              •   INDELs from the exome data:
   bcftools filter -sGIABFILTER \
      -e'MQ<45 | MQ0F>0.002034686| HOB> 0.269603| SGB>53165.5 | SGB<-85919.729 | 
IMF<0.3323922 | QUAL<20' $file.indels.vcf.gz \
     -o $out.indels.filtered.vcf.gz -O z
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Table 2. Variant annotations and cutoff values used for INDELs identified using the 
low coverage data.
Annotation Description Cutoff value
INFO/DP Raw read depth >23,758
INFO/MQ Average mapping quality <41
INFO/MQ0F Fraction of MQ0 reads (smaller is better) >0.009913696
INFO/HOB Bias in the number of HOMs number (smaller is better) >0.20265508
INFO/SGB Segregation based metric >2143.8876
INFO/SGB Segregation based metric <-29513.557
INFO/IDV Maximum number of reads supporting an indel >51
INFO/IMF Maximum fraction of reads supporting an indel <0.387097
QUAL Variant quality <20
Table 3. Variant annotations and cutoff values used for SNPs identified using the 
exome data.
Annotation Description Cutoff value
INFO/DP Raw read depth >656,519
INFO/MQ Average mapping quality <38
INFO/MQ0F Fraction of MQ0 reads (smaller is better) >0.0146629
INFO/HOB Bias in the number of HOMs number (smaller is better) >0.1536016
INFO/SGB Segregation based metric >57489.21
INFO/SGB Segregation based metric <-226326.93
QUAL Variant quality <20
Table 4. Variant annotations and cutoff values used for INDELs identified using the 
exome data.
Annotation Description Cutoff value
INFO/MQ Average mapping quality <45
INFO/MQ0F Fraction of MQ0 reads (smaller is better) >0.002034686
INFO/HOB Bias in the number of HOMs number (smaller is better) >0.269603
INFO/SGB Segregation based metric >53165.5
INFO/SGB Segregation based metric <-85919.729
INFO/IMF Maximum fraction of reads supporting an indel <0.3323922
QUAL Variant quality <20
Table 1. Variant annotations and cutoff values used for SNPs identified using the 
low coverage data.
Annotation Description Cutoff value
INFO/DP Raw read depth >24,304
INFO/MQ Average mapping quality <34
INFO/MQ0F Fraction of MQ0 reads (smaller is better) >0.049737
INFO/HOB Bias in the number of HOMs number (smaller is better) >0.1643732
INFO/SGB Segregation based metric >2347.043
INFO/SGB Segregation based metric <-64440.286
QUAL Variant quality <20
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Freebayes call set. We used a simple hard filter that discarded variants having a QUAL value less than or equal 
to 1. This filter was applied using the following command:
bcftools filter -sQUALFILTER -e'QUAL<1' $file.vcf.gz \ 
  -o $file.filtered.vcf.gz -O z
Generation of the consensus call set
First, each call set was normalized using a combination of vt normalize10 (version 0.5) and vcflib vcfallelicprimi-
tives (version v1.0.0-rc1). This procedure was necessary because sometimes the different variant callers describe 
the same variant in a different way, which makes comparison difficult and affects the integration of the different 
initial call sets. Additionally, GATK VariantsToAllelicPrimitives was used to decompose the multi-nucleotide 
polymorphisms (MNPs) that were present in the Freebayes call set.
Finally, and in order to take advantage of the strengths of each method used for the variant identification, we 
generated a consensus call set by the union of the biallelic sites from each call set and by the calculation of the 
genotype likelihoods for each site using GATK UnifiedGenotyper in ‘genotype_given_alleles’ (GGA) mode using 
the following command line:
java -jar GenomeAnalysisTK.jar \
  -T UnifiedGenotyper \
  -R $ref.fa \
  -I input.$chr:$start-$end.bam \
  -glm SNP \
  --intervals $chr:$start-$end \
  --intervals integrated.biallelic.sites.vcf.gz \
  --output_mode EMIT_ALL_SITES \
  --alleles integrated.biallelic.sites.vcf.gz \
  --interval_set_rule INTERSECTION \
  --genotyping_mode GENOTYPE_GIVEN_ALLELES \
  --max_deletion_fraction 1.5
Where $chr:$start-$end is the genomic chunk that is being analysed and integrated.biallelic.
sites.vcf.gz is the VCF containing the union of the biallelic sites for which the genotype likelihoods will 
be calculated.
We then filtered the spurious variants resulting of the union of the sites using Variant Quality Score Recalibra-
tion (VQSR) and the same parameters and training call sets that were described above used for filtering the 
supporting call set generated using GATK UnifiedGenotyper. GATK ApplyRecalibrator was used with the same 
--ts_filter_level value of 99.9 used for SNPs.
Phasing and imputation of the consensus call set. The VCF file containing the genotype likelihoods obtained 
following the procedure described in previous section was divided into single chromosome VCF files that were 
further divided into genomic chunks containing 2,100 sites of which 600 were shared between consecutive chunks. 
These chunks were processed by in parallel by Beagle11 by using the following command:
java -jar beagle.08Jun17.d8b.jar \
  chrom=$chr:$start-$end \
  gl=$chr.biallelic.GL.vcf.gz \
  out=$chr.$start.$end.beagle \
  niterations=15
Where $chr.biallelic.GL.vcf.gz is the VCF file containing the genotype likelihoods.
After processing all the chunks with Beagle we obtained an initial set of genotypes and haplotypes used in the 
next step consisting of phasing the genotype likelihoods onto a highly accurate haplotype scaffold obtained using 
SHAPEIT212 (version v2.r837) with microarray genotype data available on the same samples. This scaffold was 
obtained by leveraging family information and running SHAPEIT2 in two different independent runs on either 
the Illumina Omni 2.5 or Affymetrix 6.0 microarray data that was generated as part of the 1000 Genomes Project. 
SHAPEIT2 was run using the following settings (--window 0.5, --states 200, --burn 10, --prune 10, --main 50, 
--duohmm) and SNPs with a missing data rate above 10% and a Mendel error rate above 5% were removed 
before phasing.
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In order to phase the genotype likelihoods obtained from Beagle onto the haplotype scaffold we used SHAPEIT2. 
Genotypes called by Beagle with a posterior probability greater than 0.995 were fixed as known genotypes 
and the haplotypes estimated by Beagle were used to initialize the SHAPEIT2 phasing. This phasing was run in 
chunks of 12,250 sites with 3,500 sites overlapping between consecutive chunks. SHAPEIT2 was run using the 
following command:
shapeit -call \
  --input-gen input.shapeit.$chr.gen.gz input.shapeit.$chr.gen.sample \
  --input-init input.shapeit.$chr.hap.gz input.shapeit.hap.sample \
   --input-scaffold chip.omni.snps.$chr.haps chip.omni.snps.$chr.sample chip.
affy.snps.$chr.haps chip.affy.snps.$chr.sample  \
  --input-map $chr.gmap.gz \
  --input-thr 1 \
  --window 0.1 \
  --states 400 \
  --states-random 200 \
  --burn 0 \
  --run 12 \
  --prune 4 \
  --main 20 \
  --input-from $chunk_start \
  --input-to $chunk_end  \
   --output-max out.$chr.$chunk_start.$chunk_end.haps.gz out.$chr.$chunk_
start.$chunk_end.haps.sample
Where --input-gen specifies specifies the genotype/GL input data from Beagle, --input-init specifies the haplotypes 
from Beagle, --input-map specifies the genetic map used in the estimation, --input-scaffold gives the SNP-array 
derived haplotype scaffold obtained from SHAPEIT2. The genetic map used was downloaded from https:// 
data.broadinstitute.org/alkesgroup/Eagle/downloads/tables/genetic_map_hg38_withX.txt.gz. Each of the phased 
chunks resulting from running SHAPEIT2 were joined together using the program ligateHAPLOTYPES.
The strategy described here was used in the final phase of the 1000 Genomes Project and has been shown to produce 
low error rates for genotype calls13.
The pipelines used in this work were implemented using the eHive workflow system14 and modules developed 
in Perl and Python, which have been packaged for ease of deployment. All the analyses were run in parallel on a 
high-throughput compute cluster to ensure completion in a reasonable timeframe. Code is publicly available via 
GitHub (see software availability section)14–16.
Data set validation
To assess our call set and compare it to the released data from the final phase of the 1000 Genomes Project, we 
utilised resources from GIAB. Our strategy compares our GRCh38 calls for NA12878 with those on the same 
assembly for that sample from GIAB. In addition, we compared the 1000 Genomes variant calls for NA12878 to 
the set of calls from GIAB for NA12878 on GRCh37. NA12878 was selected for this due to the availability of high 
quality call sets. In the sequence data used in generating our call set, NA12878 has lower coverage (4.6x) than the 
average coverage (6.2x) for the WGS alignment files and has higher coverage (144.1x) than the average coverage 
(84.9x) for the WES alignment files. We assume that the conclusions derived from NA12878 can be extrapolated 
to the rest of the samples and are likely to be conservative regarding the accuracy of our calls on GRCh38. Our 
comparison approach has benefits of both enabling us to benchmark the performance on a given sample with an 
independently produced gold-standard call set and allowing us to apply the equivalent benchmark to data from 
the 1000 Genomes Project, which gives a direct indication of how our call set compares to that produced by the 1000 
Genomes Project.
In order to validate our data set we used the variants for NA12878 from the multi-sample phased VCF and 
compared them with the GIAB sites on GRCh38 downloaded from [ftp://ftp-trace.ncbi.nlm.nih.gov/giab/ftp/
release/NA12878_HG001/latest] (version 3.3.2). For comparative purposes we also compared the GRCh37 variants 
from the final phase of the 1000 Genomes Project (downloaded here) with the GRCh37 GIAB variants obtained 
here (version 3.3.2). Our comparison is restricted to regions of the genomes for which GIAB considers calls 
to be high confidence and was performed using the Nextflow17 workflow accessible from the link in the software 
availability section.
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Table 5. Site comparison for NA12878 between our call set and Genome in a Bottle (GIAB)-mapped to GRCh38 
and between the 1000 Genomes Project phase 3 (P3) call set and GIAB mapped to GRCh37. Results are shown 
for each chromosome. ‘Shared (TP)’ are the true positive variants identified in the compared call sets. ‘giab_only (FN)’ 
are the false negative variants identified by GIAB only. ‘Thiswork_only (FP)’ are the false positive variants identified in 



















(b38) 238,323 96.37 8,965 3.63 1,347 0.56 247,288 239,670
Chr1 
(b37) 242,331 98.09 4,707 1.91 1,700 0.70 247,038 244,031
Chr2 
(b38) 237,017 96.42 8,791 3.58 1,264 0.53 245,808 238,281
Chr2 
(b37) 260,921 98.14 4,942 1.86 1,209 0.46 265,863 262,130
Chr3 
(b38) 214,201 96.17 8,520 3.83 1,134 0.53 222,721 215,335
Chr3 
(b37) 218,474 97.93 4,608 2.07 926 0.42 223,082 219,400
Chr4 
(b38) 188,608 96.00 7,860 4.00 847 0.45 196,468 189,455
Chr4 
(b37) 232,888 97.93 4,927 2.07 888 0.38 237,815 233,776
Chr5 
(b38) 181,015 96.26 7,031 3.74 865 0.48 188,046 181,880
Chr5 
(b37) 193,359 95.48 9,162 4.52 766 0.39 202,521 194,125
Chr6 
(b38) 197,830 96.04 8,151 3.96 940 0.47 205,981 198,770
Chr6 
(b37) 191,018 98.05 3,801 1.95 844 0.44 194,819 191,862
Chr7 
(b38) 166,888 96.54 5,982 3.46 854 0.51 172,870 167,742
Chr7 
(b37) 167,924 97.98 3,464 2.02 712 0.42 171,388 168,636
Chr8 
(b38) 145,748 96.24 5,700 3.76 678 0.46 151,448 146,426
Chr8 
(b37) 171,950 97.76 3,937 2.24 715 0.41 175,887 172,665
Chr9 
(b38) 131,987 96.42 4,899 3.58 635 0.48 136,886 132,622
Chr9 
(b37) 132,596 97.84 2,924 2.16 581 0.44 135,520 133,177
Chr10 
(b38) 153,504 96.55 5,480 3.45 815 0.53 158,984 154,319
Chr10 
(b37) 153,080 97.87 3,338 2.13 648 0.42 156,418 153,728
Chr11 
(b38) 154,516 95.83 6,720 4.17 775 0.50 161,236 155,291
Chr11 
(b37) 155,511 97.86 3,407 2.14 609 0.39 158,918 156,120
Chr12 
(b38) 136,457 96.46 5,008 3.54 745 0.54 141,465 137,202
Chr12 
(b37) 148,026 98.03 2,972 1.97 676 0.45 150,998 148,702
The result of our comparison is shown in Table 5. The average percentage of sites among all the chromo-
somes identified in our work that were also present in GIAB represents 96.4% of the total GIAB sites. This 
percentage is comparable to 97.9% resulting from the comparison with the final phase of the 1000 Genomes Project 
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(b38) 121,294 96.89 3,889 3.11 560 0.46 125,183 121,854
Chr13 
(b37) 122,424 98.08 2,395 1.92 423 0.34 124,819 122,847
Chr14 
(b38) 99,613 96.03 4,122 3.97 493 0.49 103,735 100,106
Chr14 
(b37) 99,543 97.74 2,300 2.26 434 0.43 101,843 99,977
Chr15 
(b38) 85,881 96.59 3,031 3.41 386 0.45 88,912 86,267
Chr15 
(b37) 87,224 97.95 1,822 2.05 390 0.45 89,046 87,614
Chr16 
(b38) 54,542 96.72 1,850 3.28 282 0.51 56,392 54,824
Chr16 
(b37) 92,735 97.92 1,967 2.08 424 0.46 94,702 93,159
Chr17 
(b38) 73,765 96.69 2,524 3.31 484 0.65 76,289 74,249
Chr17 
(b37) 76,187 98.27 1,341 1.73 441 0.58 77,528 76,628
Chr18 
(b38) 73,419 96.89 2,360 3.11 344 0.47 75,779 73,763
Chr18 
(b37) 93,004 97.97 1,923 2.03 365 0.39 94,927 93,369
Chr19 
(b38) 56,210 95.27 2,788 4.73 461 0.81 58,998 56,671
Chr19 
(b37) 59,138 97.93 1,248 2.07 376 0.63 60,386 59,514
Chr20 
(b38) 64,786 96.78 2,154 3.22 419 0.64 66,940 65,205
Ch20 
(b37) 64,827 97.89 1,400 2.11 275 0.42 66,227 65,102
Chr21 
(b38) 42,453 96.96 1,329 3.04 225 0.53 43,782 42,678
Chr21 
(b37) 43,941 98.13 836 1.87 178 0.40 44,777 44,119
Chr22 
(b38) 33,351 96.81 1,099 3.19 193 0.58 34,450 33,544
Chr22 
(b37) 36,132 98.16 678 1.84 207 0.57 36,810 36,339
ChrX 
(b38)* 109 93.97 7 6.03 2 1.80 116 111
AVG** 
(b38) 129,609 96.41 4,921 3.59 670 0.53 134,530 130,280
AVG 
(b37) 138,329 97.86 3,095 2.14 627 0.45 141,424 138,955
* Only PAR regions
** Not considering chrX for the calculation
(P3). Additionally, the percentage of sites identified in our call set but not in GIAB is 0.5%, which is comparable 
to the 0.4% obtained in the comparison with 1000 Genomes P3. Taken together, these results demonstrate both 
the high sensitivity and high specificity of our callset.
Data availability
The variants resulting from this work are available in the European Variation Archive. Accession number 
PRJEB30460.
This call set is also available from the International Genome Sample Resource (IGSR) [PMID: 27638885] at: http://
ftp.1000genomes.ebi.ac.uk/vol1/ftp/data_collections/1000_genomes_project/release/20181203_biallelic_SNV/.
Page 12 of 20
Wellcome Open Research 2019, 4:50 Last updated: 15 MAY 2019
Software availability


































































































































Page 13 of 20
Wellcome Open Research 2019, 4:50 Last updated: 15 MAY 2019
1. 1000 Genomes Project Consortium, Auton A, Brooks LD, et al.: 
A global reference for human genetic variation. Nature. 2015; 
526(7571): 68–74.  
PubMed Abstract | Publisher Full Text | Free Full Text 
2. Zheng-Bradley X, Flicek P: Applications of the 1000 Genomes 
Project resources. Brief Funct Genomics. 2017; 16(3): 163–170. 
PubMed Abstract | Publisher Full Text | Free Full Text 
3. Zheng-Bradley X, Streeter I, Fairley S, et al.: Alignment of 1000 
Genomes Project reads to reference assembly GRCh38. 
Gigascience. 2017; 6(7): 1–8.  
PubMed Abstract | Publisher Full Text | Free Full Text 
4. 1000 Genomes Project Consortium, Abecasis GR, Altshuler D, et 
al.: A map of human genome variation from population-scale 
sequencing. Nature. 2010; 467(7319): 1061–1073.  
PubMed Abstract | Publisher Full Text | Free Full Text 
5. 1000 Genomes Project Consortium, Abecasis GR, Auton A, et al.: An 
integrated map of genetic variation from 1,092 human genomes. 
Nature. 2012; 491(7422): 56–65.  
PubMed Abstract | Publisher Full Text | Free Full Text 
6. Jun G, Flickinger M, Hetrick KN, et al.: Detecting and estimating 
contamination of human DNA samples in sequencing and array-
based genotype data. Am J Hum Genet. 2012; 91(5): 839–848. 
PubMed Abstract | Publisher Full Text | Free Full Text 
7. Garrison E, Marth G: Haplotype-based variant detection from 
short-read sequencing. arXiv preprint. arXiv: 1207.3907 [q-bio.GN]. 
2012.  
Reference Source
8. McKenna A, Hanna M, Banks E, et al.: The Genome Analysis 
Toolkit: a MapReduce framework for analyzing next-generation 
DNA sequencing data. Genome Res. 2010; 20(9): 1297–1303. 
PubMed Abstract | Publisher Full Text | Free Full Text 
9. Zook JM, Chapman B, Wang J, et al.: Integrating human sequence 
data sets provides a resource of benchmark SNP and indel 
genotype calls. Nat Biotechnol. 2014; 32(3): 246–251.  
PubMed Abstract | Publisher Full Text 
10. Tan A, Abecasis GR, Kang HM: Unified representation of genetic 
variants. Bioinformatics. 2015; 31(13): 2202–2204.  
PubMed Abstract | Publisher Full Text | Free Full Text 
11. Browning SR, Browning BL: Rapid and accurate haplotype phasing 
and missing-data inference for whole-genome association 
studies by use of localized haplotype clustering. Am J Hum 
Genet. 2007; 81(5): 1084–1097.  
PubMed Abstract | Publisher Full Text | Free Full Text 
12. Delaneau O, Marchini J, Zagury JF: A linear complexity phasing 
method for thousands of genomes. Nat Methods. 2011; 9(2): 
179–181.  
PubMed Abstract | Publisher Full Text 
13. Delaneau O, Marchini J, 1000 Genomes Project Consortium et al.: 
Integrating sequence and array data to create an improved 1000 
Genomes Project haplotype reference panel. Nat Commun. 2014; 
5: 3934.  
PubMed Abstract | Publisher Full Text | Free Full Text 
14. Severin J, Beal K, Vilella AJ, et al.: eHive: an artificial intelligence 
workflow system for genomic analysis. BMC Bioinformatics. 2010; 
11: 240.  
PubMed Abstract | Publisher Full Text | Free Full Text 
15. Lowy E, GabeAldam, Fairley S: igsr/igsr_analysis: First release of 
code (Version v1.0.0). Zenodo. 2019.  
http://www.doi.org/10.5281/zenodo.2573911
16. istreeter, Richardson D, HollyZB, et al.: EMBL-EBI-GCA/reseqtrack: 
zenodo (Version zenodo). Zenodo. 2019.  
http://www.doi.org/10.5281/zenodo.2573969
17. Di Tommaso P, Chatzou M, Floden EW, et al.: Nextflow enables 
reproducible computational workflows. Nat Biotechnol. 2017; 
35(4): 316–319.  
PubMed Abstract | Publisher Full Text 
18. Poznik GD, Xue Y, Mendez FL, et al.: Punctuated bursts in human 
male demography inferred from 1,244 worldwide Y-chromosome 
sequences. Nat Genet. 2016; 48(6): 593–599.  
PubMed Abstract | Publisher Full Text | Free Full Text 
References
Grant information
This work was completed thanks to the funding from the Wellcome Trust (grant number 104947) and the European 
Molecular Biology Laboratory.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the 
manuscript.
Acknowledgements
We would like to thank Petr Danecek (Matthew Hurles Group, Wellcome Sanger Institute), Erik Garrison (Durbin 
Group, Wellcome Sanger Institute) and Tommy Carstensen (Global Health & Population Science, Department 
of Medicine, University of Cambridge) for participating in discussions on the methodology used in this work. 
Shane McCarthy (Department of Genetics, University of Cambridge) for detailed advice and discussion of 
the project plan. We would also like to thank Zamin Iqbal (Iqbal group, EMBL-EBI) for discussions on the 
project methodology and outputs. In addition, our thanks go to the Systems Infrastructure team of EMBL-EBI 
for providing continuous support and maintenance of the computing infrastructure required to complete this 
work. Finally, we would like to thank Tommy Carstensen for providing the liftover of the array data used for the 
phasing of the variants identified in this work.
Members of the 1000 Genomes Project Consortium are listed in the Supplementary Note, contained within the 
Supplementary Text and Figures) of Poznik et al.18.
Author information
Xiangqun Zheng-Bradley is currently at ‘Illumina Center, Illumina UK Ltd., Cambridge, UK’.
Page 14 of 20
Wellcome Open Research 2019, 4:50 Last updated: 15 MAY 2019
 Open Peer Review
  Current Peer Review Status:
Version 1
 10 April 2019Reviewer Report
https://doi.org/10.21956/wellcomeopenres.16504.r35054































Page 15 of 20






















































small-variant calls in human genomes. . 2019.   |   Nat Biotechnol PubMed Abstract Publisher Full Text
2. Zook JM, McDaniel J, Olson ND, Wagner J, Parikh H, Heaton H, Irvine SA, Trigg L, Truty R, McLean
CY, De La Vega FM, Xiao C, Sherry S, Salit M: An open resource for accurately benchmarking small
Page 16 of 20
Wellcome Open Research 2019, 4:50 Last updated: 15 MAY 2019
 CY, De La Vega FM, Xiao C, Sherry S, Salit M: An open resource for accurately benchmarking small
variant and reference calls. . 2019.   |   Nat Biotechnol PubMed Abstract Publisher Full Text
Is the rationale for creating the dataset(s) clearly described?
Yes
Are the protocols appropriate and is the work technically sound?
Partly
Are sufficient details of methods and materials provided to allow replication by others?
Yes




I have read this submission. I believe that I have an appropriate level of expertise to state that I
do not consider it to be of an acceptable scientific standard, for reasons outlined above.
 08 April 2019Reviewer Report
https://doi.org/10.21956/wellcomeopenres.16504.r35051
© 2019 Church D. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.















Page 17 of 20










































Page 18 of 20


























Resolving the full spectrum of human genome variation using Linked-Reads. .   (4):Genome Res 29
635-645   |   PubMed Abstract Publisher Full Text
Is the rationale for creating the dataset(s) clearly described?
Partly
Are the protocols appropriate and is the work technically sound?
Partly
Are sufficient details of methods and materials provided to allow replication by others?
Yes





I have read this submission. I believe that I have an appropriate level of expertise to state that I
do not consider it to be of an acceptable scientific standard, for reasons outlined above.
1
Page 19 of 20
Wellcome Open Research 2019, 4:50 Last updated: 15 MAY 2019
 
Page 20 of 20
Wellcome Open Research 2019, 4:50 Last updated: 15 MAY 2019
